Search research articles
Contact Us
Filters
Showing results (41-50 of 170) with videos related to
Page
of 17
Sort By:
Nanomaterials (Basel, Switzerland)
|
November 26, 2024
Harnessing a Safe Novel Lipid Nanoparticle: Targeted Oral Delivery to Colonic Epithelial and Macrophage Cells in a Colitis Mouse Model
Rabeya Jafrin Mow, Michal Pawel Kuczma, Xiaodi Shi, et al.
Molecular Pharmacology
|
May 22, 2013
Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity
Adam B Roberts, Bret D Wallace, Madhu Kumar Venkatesh, et al.
BMC Cancer
|
November 25, 2010
Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
Velasco Cimica, Melissa E Smith, Zhikai Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2008
Rhabdoid tumor growth is inhibited by flavopiridol
Melissa E Smith, Velasco Cimica, Srinivasa Chinni, et al.
Environmental Health Perspectives
|
June 19, 2010
Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast database
Sandhya Kortagere, Matthew D Krasowski, Erica J Reschly, et al.
Pharmaceutical Research
|
May 6, 2009
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists
Arunima Biswas, Sridhar Mani, Matthew R Redinbo, et al.
Biochemical Pharmacology
|
September 17, 2011
Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene
Lucie Krausova, Lucie Stejskalova, Hongwei Wang, et al.
Investigational New Drugs
|
May 4, 2004
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium
Hedy L Kindler, Anjali Avadhani, Kurombi Wade-Oliver, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 2, 2023
Maternal PBDE exposure disrupts gut microbiome and promotes hepatic proinflammatory signaling in humanized PXR-transgenic mouse offspring over time
Sarah Kim, Hao Li, Yan Jin, et al.
Journal of Hematology & Oncology
|
April 26, 2017
Recent advances of highly selective CDK4/6 inhibitors in breast cancer
Hanxiao Xu, Shengnan Yu, Qian Liu, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 170) with videos related to
Sort By:
Page
of 17
Nanomaterials (Basel, Switzerland)
|
November 26, 2024
Harnessing a Safe Novel Lipid Nanoparticle: Targeted Oral Delivery to Colonic Epithelial and Macrophage Cells in a Colitis Mouse Model
Rabeya Jafrin Mow, Michal Pawel Kuczma, Xiaodi Shi, et al.
Molecular Pharmacology
|
May 22, 2013
Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity
Adam B Roberts, Bret D Wallace, Madhu Kumar Venkatesh, et al.
BMC Cancer
|
November 25, 2010
Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
Velasco Cimica, Melissa E Smith, Zhikai Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2008
Rhabdoid tumor growth is inhibited by flavopiridol
Melissa E Smith, Velasco Cimica, Srinivasa Chinni, et al.
Environmental Health Perspectives
|
June 19, 2010
Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast database
Sandhya Kortagere, Matthew D Krasowski, Erica J Reschly, et al.
Pharmaceutical Research
|
May 6, 2009
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists
Arunima Biswas, Sridhar Mani, Matthew R Redinbo, et al.
Biochemical Pharmacology
|
September 17, 2011
Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene
Lucie Krausova, Lucie Stejskalova, Hongwei Wang, et al.
Investigational New Drugs
|
May 4, 2004
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium
Hedy L Kindler, Anjali Avadhani, Kurombi Wade-Oliver, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 2, 2023
Maternal PBDE exposure disrupts gut microbiome and promotes hepatic proinflammatory signaling in humanized PXR-transgenic mouse offspring over time
Sarah Kim, Hao Li, Yan Jin, et al.
Journal of Hematology & Oncology
|
April 26, 2017
Recent advances of highly selective CDK4/6 inhibitors in breast cancer
Hanxiao Xu, Shengnan Yu, Qian Liu, et al.
Page
of 17